← Eichor
Study identifier: NCT07091344 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cognitive and Metacognitive Evaluation in VR-Based Avatar Therapy for Psychosis

Condition: Schizophrenia Disorders · Treatment Resistant Hallucinations  ·  Sponsor: Fundació Sant Joan de Déu

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study aims to evaluate the relationship between cognitive, metacognitive and social cognition variables in patients with psychosis undergoing VR-based Avatar Therapy for the treatment of auditory hallucinations. In addition to the primary intervention, participants will be assessed using validated tools for emotion recognition, attributional style, theory of mind, neurocognition, and metacognition. The study also explores the potential role of trauma as a predisposing factor. Assessments will be conducted at four time points: screening (week 0), baseline (week 12), intervention period (weeks 12-24), and post-therapy follow-up (week 24). By investigating these variables, this study seeks to better understand their impact on treatment outcomes and contribute to the development of personalized therapeutic approaches.

This description comes directly from the study's public registry record.

Talk to the study team

Susana Ochoa, PhD  ·  +34936406350  ·  susana.ochoa@sjd.es

Luciana Díaz-Cutraro, PhD  ·  +34936406350  ·  luciana.diaz@sjd.es

Always discuss trial participation with your own doctor first.

Locations (1)

Fundació Sant Joan de Déu - Unitat de Recerca del Parc Sanitari Sant Joan de DéuBarcelona, Catalonia, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07091344